Judge Axes Benicar Fee Suit, Says Company Didn’t Overcharge

By Ryan Harroff (May 6, 2022, 4:50 p.m. EDT) — Mazie Slater Katz & Freeman LLC beat a lawsuit Friday that alleged it overcharged its customers in a multidistrict litigation over gastrointestinal injuries related to hypertension drug Benicar and its generic Olmesartan after the New Jersey court found that a state attorney’s fee rule did not apply to MDL.

A New Jersey federal judge granted Mazie Slater’s motion to dismiss the proposed class action, writing that the nearly $9 million award to the company was “well within the reasonable and fair percentages of Third Circuit examples.” . The court accepted the company’s argument from its severance offer that a state rule…

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!

TRY LAW360 FREE FOR SEVEN DAYS

Comments are closed.